The Venture Codex Logo

The Venture Codex

Overview

Investment firm supporting life science and healthcare companies.

Founded

2012

Deals ยท 12mo

6

Stage focus

Series A
Series B
Series C

Geographic focus

China
United States

Sector focus

Financial Services
Health Care
Venture Capital

Investment portfolio

64rounds
NAMEDATESIZE
Synphatec
Sep 2026Led
$50 MSeries A
Serapha Bio
Jun 2026Participated
$138 MSeries A
Vivacta Biotechnology (Shanghai) Co., Ltd.
Apr 2026Led
$50 MSeries A
Syneron Bio
Apr 2026Led
$150 MSeries B
Excellergy
Dec 2025Participated
$70 MSeries A
Phrontline Biopharma
Nov 2025Participated
$60 MSeries A
Ottimo Pharma
Dec 2024Participated
$140 MSeries A
Phrontline Biopharma
Jun 2024Led
$14 MSeries A
Aardvark Therapeutics
May 2024Led
$85 MSeries C
Firefly Bio
Feb 2024Participated
$94 MSeries A
Yaotang Biology
Nov 2023Led
$14 MSeries A
Adela
Sep 2023Participated
$48 MOther Equity
Synphatec
Sep 2026Led
$50 MSeries A
Serapha Bio
Jun 2026Participated
$138 MSeries A
Vivacta Biotechnology (Shanghai) Co., Ltd.
Apr 2026Led
$50 MSeries A
Syneron Bio
Apr 2026Led
$150 MSeries B
Excellergy
Dec 2025Participated
$70 MSeries A
Phrontline Biopharma
Nov 2025Participated
$60 MSeries A
Ottimo Pharma
Dec 2024Participated
$140 MSeries A
Phrontline Biopharma
Jun 2024Led
$14 MSeries A
Aardvark Therapeutics
May 2024Led
$85 MSeries C
Firefly Bio
Feb 2024Participated
$94 MSeries A
Yaotang Biology
Nov 2023Led
$14 MSeries A
Adela
Sep 2023Participated
$48 MOther Equity
64
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Decheng Capital: 64 funding rounds are recorded in the selected participation categories.All available history.
Decheng Capital: 64 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A810
Series B88
Series C+516
Other Equity54

Monthly Deal Activity

Decheng Capital: 64 deals are recorded across 177 months.All available history.
Decheng Capital: 64 deals are recorded across 177 months. All available history
MonthDeals
Feb '121
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '131
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '141
Aug '140
Sep '140
Oct '141
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '162
Oct '160
Nov '161
Dec '160
Jan '170
Feb '170
Mar '170
Apr '171
May '171
Jun '170
Jul '170
Aug '171
Sep '170
Oct '170
Nov '171
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '181
Jul '182
Aug '182
Sep '180
Oct '182
Nov '180
Dec '181
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '191
Nov '190
Dec '190
Jan '203
Feb '200
Mar '201
Apr '200
May '200
Jun '204
Jul '202
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '211
Feb '210
Mar '212
Apr '211
May '212
Jun '211
Jul '211
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '221
Feb '221
Mar '220
Apr '220
May '221
Jun '222
Jul '220
Aug '220
Sep '221
Oct '220
Nov '222
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '231
Jul '230
Aug '232
Sep '232
Oct '230
Nov '231
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '241
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '251
Jan '260
Feb '260
Mar '260
Apr '262
May '260
Jun '261
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Decheng Capital: Health & Life Sciences is the largest displayed sector by deal count (63 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Decheng Capital: Health & Life Sciences is the largest displayed sector by deal count (63 deals). All available history
SectorDeals
Health & Life Sciences63
Manufacturing4
Space & Frontier Tech2
Marketing & Advertising1
AI & Machine Learning1
Professional Services1
Data, Analytics & IT1

Deal Size Distribution

Decheng Capital: 64 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Decheng Capital: 64 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M9
$25M-$50M12
$50M-$100M21
$100M-$250M19
$250M-$500M3
$500M-$1B0
$1B+0

Deals By Geography

Decheng Capital: United States has the largest recorded deal count among the displayed regions (50 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Decheng Capital: United States has the largest recorded deal count among the displayed regions (50 deals). All available history
RegionDeals
United States50
China11
Europe2
India1
Decheng Capital: 20 co-investors are shown, with OrbiMed sharing 12 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Decheng Capital: Led accounts for 41% and participating for 59% of round participation.All available history.
Decheng Capital: Led accounts for 41% and participating for 59% of round participation. All available history
CategoryDeals (count)Share (%)
Led2641%
Participating3859%
Decheng Capital: Single-lead accounts for 65% and co-led for 35% of lead dynamics.All available history.
Decheng Capital: Single-lead accounts for 65% and co-led for 35% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1765%
Co-led935%

Team

Dan Zabrowski

Venture Partner

Min Cui

Founder and Managing Director